Table 2.
Patient number | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 | Patient 12 | Patient 13 | Patient 14 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex | Female | Female | Male | Male | Male | Male | Female | Male | Female | Female | Male | Male | Male | Male |
Age (years) | 11 | 60 | 62 | 54 | 58 | 51 | 62 | 39 | 38 | 22 | 30 | 72 | 36 | 48 |
Onset pattern | Acute | Acute | Chronic | Acute | Acute | Acute | Acute | Chronic | Chronic | Acute | Subacute | Acute | Chronic | Chronic |
Initial symptoms | Fever, hallucinations, dizziness, headache. | Cognitive impairment | Ataxia, dizziness | Gastrointestinal symptoms | Epilepsy, cognitive impairment | Gastrointestinal symptoms | Fever | Auditory hallucinations | Ataxia, dizziness | Epilepsy | Gastrointestinal symptoms | Gastrointestinal symptoms | Gastrointestinal symptoms | Dizziness, ataxia |
Primary symptoms | Psychiatric and behavioral abnormalities | Cognitive impairment, limb convulsions | Cerebellar ataxia | Ataxia, nystagmus | Epilepsy, cognitive impairment | Psychiatric and behavioral abnormalities, nausea, vomiting | Cognitive impairment | Psychiatric and behavioral abnormalities, cognitive impairment, auditory and visual hallucinations | Sleep disturbance, dizziness, weight loss, myodystony | consciousness disorder, epilepsy | Psychiatric and behavioral abnormalities, delirium, myoclonus, hallucinations, cognitive impairment, weight loss, diarrhea | Cognitive impairment, psychiatric and behavioral abnormalities, sleep disorders, hallucinations, abdominal pain, diarrhea | Memory decline, bulbar syndrome, myoclonus, diarrhea | Ataxia, nystagmus, weakness in the lower limbs, dizziness |
Neoplasms, infections, and immune-related factors | Upper respiratory tract infection | Breast cancer | (−) | (−) | (−) | (−) | Upper respiratory tract infection | (−) | HSV-1 | (−) | Ankylosing spondylitis Rheumatoid arthritis Inflammatory bowel disease |
Upper respiratory tract infection | (−) | (−) |
CSF testing | Normal | Protein: 91.8 mg/dL | Protein: 57 mg/dL | Normal | Chloride: 133 mmol/L, OCB(+), IgG index:0.94 | Normal | Normal | Normal | Normal | Normal | Normal | Glucose: 5.00 mmol/L,OCB(+), IgG index: 0.86 | Normal | Chloride: 139 mmol/L |
DPPX antibodies in serum | 1:100 | 1:32 | 1:100 | 1:10 | 1:320 | NA | 1:100 | NA | 1:320 | 1:100 | (−) | 1:100 | 1:100 | 1:32 |
DPPX antibodies in CSF | (−) | (−) | 1:10 | (−) | 1:100 | 1:10 | (−) | 1:1 | 1:32 | (−) | 1:32 | 1:32 | (−) | 1:1 |
Other positive autoimmune antibodies | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | (−) | Anti-CASPR2 antibody, 1:10 in CSF | (−) | Anti-NMDAR antibody, 1:32 in serum | (−) |
MRI | Normal | Abnormal swelling and enhancement signals in the cortical areas of the left temporal lobe and parieto-occipital lobe. | Normal | Normal | Normal | Normal | Bilateral frontal and parietal white matter, bilateral basal ganglia: Multiple small hyperintense lesions | Normal | Cerebellar atrophy | Hippocampal swelling | Normal | Mild atrophy of the left hippocampus | Normal | Cerebellar atrophy |
CSF, cerebrospinal fluid; MRI, magnetic resonance imaging.